Business in the Burbs

Regeneron announces agreement with Columbia

September

Regeneron Pharmaceuticals Inc., a biotech company based in Eastview, announced an agreement to provide access to company technolgy to researchers at Columbia University in New York looking to discover new medications.

Regeneron said that the technology covered under the agreement, known as VelocImmune, increases the speed of human antibody development.

Regeneron added that it hopes to develop similar agreements with other major universities and research institutes.

This entry was posted on Tuesday, September 16th, 2008 at 10:58 am by Jay Loomis. You can follow any responses to this entry through the RSS 2.0 feed.
Category: Biopharmaceutical

Print | Email

It is a condition of your use of the comment features associated with the blogs that you do not: Use the site to post or transmit any unlawful, threatening, abusive, libelous, defamatory, obscene, vulgar, pornographic, profane or indecent information of any kind, including without limitation any transmissions constituting or encouraging conduct that would constitute a criminal offense, give rise to civil liability or otherwise violate any local, state, national or international law. You alone are responsible for the material you post or send. Refer to the Terms of Service.